Top

22-04-2016 | Sarcoma | Book chapter | Article

Soft Tissue Sarcoma Brachytherapy

Authors: James Fontanesi, MD, Michael Mott, MD, Jeffrey Margolis, MD, Gabrielle Monit, MS, PA-C, Alain Gerbaulet, MD

Publisher: Springer International Publishing

Abstract

Soft tissue sarcomas (STS) are a diffuse group of malignancies that arise from connective tissues such as fat, muscle, nerves, and blood vessels. They account for approximately 1 % of all adult malignancies and approximately 10 % of pediatric malignancies. They do not respect age, appearing in all age groups. Here we present brachytherapy as primary therapy or an adjunct to management.

Morgagni G. De Sedibus, Et Causis Morborum Per Anatomen Indagatis Libri Quinque. Published 1761 by Ex Typographia Rmondiniana in Venetiis. Written in Latin

Gronchi A, Casali PG (2013) Adjuvant therapy for high-risk soft tissue sarcoma in the adult. Curr Treat Options Oncol 14(3):415–424. doi:10.1007/s11864-013-0243-7 CrossRefPubMed

Cancer Facts & Figures 2014. American Cancer Society

Fong Y, Coit DG, Woodruff JM et al (1993) Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217(1):72–77CrossRefPubMedPubMedCentral

Nelen SD, Vogelaar FJ, Gilissen F et al (2013) Case report, lymph node metastasis after a soft tissue sarcoma of the leg: a case report and a review of the literature. Case Rep Surg 2013:930361. http://dx.doi.org/10.1155/2013/930361

Mazeron JJ, Suit HD (1987) Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 60(8):1800–1808CrossRefPubMed

Daigeler A, Kuhnen C, Moritz R et al (2009) Lymph node metastases in soft tissue sarcomas: a single center analysis of 1,597 patients. Arch Surg 394(2):321–329CrossRef

Billingsley KG, Lewis JJ, Leung DH et al (1999) Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer 85(2):389–395CrossRefPubMed

Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14(5):1679–1689PubMed

10.

Wexler LH, Helman LJ (1994) Pediatric soft tissue sarcomas. CA Cancer J Clin 44(4):211–247CrossRefPubMed

11.

Neville HL, Raney RB, Andrassy RJ et al (2000) Multidisciplinary management of pediatric soft-tissue sarcoma. Oncology 14(10):1471–1481; discussion 1482–1486, 1489–1490PubMed

12.

Spunt S, Catherine S, Poquette A et al (1999) Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol 17(2):3697–3705PubMed

13.

Zahm SH, Fraumeni JF (1997) The epidemiology of soft tissue sarcoma. Semin Oncol 24(5):504–514PubMed

14.

Ferrari A, Bisogno G, Macaluso A (2007) Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer 109(7):1406–1412CrossRefPubMed

15.

Campos FG, Martinez C, Novaes M et al (2015) Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis. Cancer 14(2):211–219

16.

Goto M, Miller RW, Ishikawa Y et al (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5(4):239–246PubMed

17.

Kleinerman RA, Schonfeld SJ et al (2012) Sarcomas in hereditary retinoblastoma. Clin Sarcoma Res 2(1):15. doi:10.1186/2045-3329-2-15 CrossRefPubMedPubMedCentral

18.

Cohen RJ, Curtis RE, Inskip PD et al (2005) The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 103(11):2391–2396CrossRefPubMed

19.

McClain KL, Leach CT, Jenson HB et al (1995) Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 332(1):12–18CrossRefPubMed

20.

Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F et al (2000) Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 231(3):380–386CrossRefPubMedPubMedCentral

21.

O’Donnell PW, Griffin AM, Eward WC et al (2014) The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer 120(18):2866–2875CrossRefPubMed

22.

Zagars GK, Ballio MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97(10):2530–2543CrossRefPubMed

23.

Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196(3):305–315CrossRefPubMedPubMedCentral

24.

Swallow CJ, Catton CN (2007) Local management of adult soft tissue sarcomas. Semin Oncol 34(3):256–269CrossRefPubMed

25.

Levine EA (1999) Prognostic factors in soft tissue sarcoma. Semin Surg Oncol 17(1):23–32CrossRefPubMed

26.

Jones NB, Iwenofu H, Scharschmidt T et al (2012) Prognostic factors and staging for soft for soft tissue sarcomas: an update. Surg Oncol Clin N Am 21(2):187–200. doi:10.1016/j.soc.2011.12.003, Epub 2012 Jan 9CrossRefPubMed

27.

Baldini EH, Goldberg J, Jenner C et al (1999) Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. Clin Oncol 17(10):3252–3259

28.

Curtis KK, Ashman JB, Beauchamp CP et al (2011) Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiat Oncol 6:91. doi:10.1186/1748-717X-6-91 CrossRefPubMedPubMedCentral

29.

Fein DA, Lee WR, Lanciano RM (1995) Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: Do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local Control? Int J Radiati Oncol Biol Phys 32(4):969–976CrossRef

30.

Cai L, Mirimanoff RO, Mouhsine E et al (2013) Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients. Rare Tumors 5(4):e55. doi:10.4081/rt.2013.e55 CrossRefPubMedPubMedCentral

31.

Folkert MR, Singer S, Brennan MF et al (2014) Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol 32(29):3236–3241. doi:10.1200/JCO.2013.53.9452

32.

Pan E, Goldberg SI, Chen YL et al (2014) Role of post-operative boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol 110(7):817–822. doi:10.1002/jso.23741, Epub 2014 Aug 11CrossRefPubMed

33.

Dincbas FO, Oksuz DC, Yetmen O et al (2014) Neoadjuvant treatment with preoperative radiotherapy for extremity soft tissue sarcomas; long-term results from a single institution in Turkey. Asian Pac J Cancer Prev 15(4):1775–1781CrossRefPubMed

34.

Mullen JT, Kobayashi W, Wang JJ et al (2012) Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas. Cancer 118(15):3758–3765. doi:10.1002/cncr.26696 CrossRefPubMed

35.

Look Hong NJ, Hornicek F, Harmon DC et al (2013) Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10 year single institution retrospective study. Eur J Cancer 49(4):875–883. doi:10.1016/j.ejca.2012.10.002 CrossRefPubMedPubMedCentral

36.

Felderhof JM, Creutzberg CL, Putter H et al (2013) Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy. Acta Oncol 52(4):745–752. doi:10.3109/0284186X.2012.709947 CrossRefPubMed

37.

Trovik CS, Scandinavian Sarcoma Group Project (2001) Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project. Acta Orthop Scand Suppl 72(300):1–31PubMed

38.

ESMO/European Sarcoma Network Working Group (2014) ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Soft tissue and visceral sarcomas. Ann Oncol 25(Suppl 3):iii102–iii112. doi:10.1093/annonc/mdu254 CrossRef

39.

Holloway C, DeLaney T, Alektiar KM et al (2013) American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy 12:179–190CrossRefPubMed

40.

Grimer R, Judson I, Peake D et al (2010) Guidelines for the management of soft tissue sarcomas: British Sarcoma Group. Sarcoma 2010:506182. doi:10.1155/2010/506182 PubMedPubMedCentral

41.

Lartigau E, Gerbaulet A (2002) GEC/ESTRO soft tissue sarcomas of the extremities in adults. ACCO, Leuven, Belgium. GEC-ESTRO Handbook 2002

42.

NCCN Guidelines; Version 2 (2014) National comprehensive cancer network, soft tissue sarcoma. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

43.

Ren C, Shi R, Min L et al (2014) Experience of interstitial permanent I 125 brachytherapy for extremity soft tissue sarcomas. Clin Oncol 26(4):230–235. doi:10.1016/j.clon.2014.01.004 CrossRef

44.

Rosenblatt E, Meushar N, Bar-Deroma R et al (2003) Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience. Isr Med Assoc J 5(8):547–551PubMed

45.

Petera J, Soumarova R, Ruzickova J et al (2010) Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: a multicentric experience. Ann Surg Oncol 17(1):206–210. doi:10.1245/s10434-00-0684-1 CrossRefPubMed

46.

Itami J, Sumi M, Beppu Y (2010) High-dose rate brachytherapy alone in postoperative soft tissue sarcomas with close or positive margins. Brachytherapy 9(4):349–353. doi:10.1016/j.brachy.2009.07.012 CrossRefPubMed

47.

San Miguel I, San Julian M, Cambeiro M et al (2011) Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater that conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 81(4):e529–e539. doi:10.1016/j.ijrobp.2011.04.063 CrossRefPubMed

48.

Fairweather M, Wang J, Devlin PM et al (2015) Safety and efficacy of radiation dose delivered via Iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol 22(5):1455–1463CrossRefPubMed

49.

Alektiar KM, Leung DH, Brennan MF et al (1996) The effect of combined external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin. Int J Radiat Oncol Biol Phys 36(2):321–324CrossRef

50.

Youssef E, Fontanesi J, Mott M et al (2002) Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys 54(2):514–519CrossRefPubMed

51.

Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. Clin Oncol 14(3):859–868

52.

Beltrami G, Rὔdiger HA, Mela MM et al (2008) Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas. Eur J Surg Oncol 34(7):811–816CrossRefPubMed

53.

Alektiar K, Zelefsky M, Brennan M (2000) Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 47(5):1273–1279CrossRefPubMed

54.

Dörr W, Kallfels S, Herrmann T (2013) Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated 1970 and 1997. Strahlenther Onkol 189(7):529–534. doi:10.1007/s00066-013-0361-y CrossRefPubMed

55.

Paulino AC (2004) Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 60(1):265–274CrossRefPubMed

56.

Hennewig U, Kaatsch P, Blettner M et al (2014) Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case-control study. Radiat Environ Biophys 53(3):485–493. doi:10.1007/s00411-014-0550-9 CrossRefPubMed

57.

Guerin S, Guibout C, Shamsaldin A et al (2007) Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study. Int J Cancer 120(1):96–102CrossRefPubMed

58.

Krasin MJ, Davidoff AM, Xiong X et al (2010) Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 76(3):874–878. doi:10.1016/j.ijrobp.2009.02.074 CrossRefPubMedPubMedCentral

59.

Rodeberg RD, Wharam MD, Lyden ER et al (2015) Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomysarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Int J Cancer 137(1):204–211. 2014 UICC. doi:10.1002/ijc.29351

60.

Cecchetto G, Modesto CM, Sotti G et al (2000) Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88. Med Pediatr Oncol 34:97–101CrossRefPubMed

61.

Gerbaulet A, Panis X, Flamant F, Chassagne D (1985) Iridium afterloading curietherapy in the treatment of pediatric malignancies. The Institut Gustave Roussy experience. Cancer 56(6):1274–1279CrossRefPubMed

62.

Fontanesi J, Rao BN, Fleming ID et al (1994) Pediatric brachytherapy. The St. Jude Children’s Research Hospital experience. Cancer 74(2):733–739CrossRefPubMed

63.

Merchant TE, Parsh N, del Valle PL et al (2000) Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 46(2):427–432CrossRefPubMed

64.

Pötter R, Knocke TH, Kovacs G et al (1995) Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing’s sarcoma. Klin Padiatr 207(4):164–173CrossRefPubMed

65.

Martelli H, Haie-Meder C, Branchereau S et al (2009) Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 44(1):190–196. doi:10.1016/j.jpedsurg.2008.10.040 CrossRefPubMed

66.

Viani GA, Novaes PE, Jacinto AA et al (2008) High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience. Radiat Oncol 3:9. doi:10.1186/1748-717X-3-9 CrossRefPubMedPubMedCentral

67.

Folkert MR, Tong WY, LaQuaglia MP et al (2014) 20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations. Int Radiat Oncol Biol Phys 90(2):362–368. doi:10.1016/j.ijrobp.2014.06.016 CrossRef

Medicine Matters Oncology

Abstract